Clinical trial
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young…
NCT00268528 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00268528 |
|---|---|
| Title | Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission |
| Official title | Understanding the Ethnic and Racial Differences in Survival in Children With Acute Lymphoblastic Leukemia |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Childhood Acute Lymphoblastic Leukemia in Remission |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Methotrexate, Questionnaire Administration, Study of Socioeconomic and Demographic Variables |
| Enrollment | 720 |
| Start date | May 30, 2005 |
| Primary completion | Mar 5, 2012 |
| Completion | Jun 30, 2020 |
| First posted | Dec 22, 2005 |
| Last update posted | Jul 7, 2020 |
| Countries | Australia, Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: